RANKL Inhibition and Breast Tissue Biomarkers

NCT03629717 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Prevention
Mammographic Density

Interventions

PROCEDURE: Ultrasound-guided core needle biopsy
DRUG: Denosumab
PROCEDURE: Blood draw
DRUG: Calcium
DRUG: Vitamin D

Sponsor

Washington University School of Medicine